DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Netazepide is an investigational drug.
There have been 6 clinical trials for Netazepide. The most recent clinical trial was a Phase 1 trial, which was initiated on January 1st 2011.
The most common disease conditions in clinical trials are Carcinoid Tumor, Atrophy, and Barrett Esophagus. The leading clinical trial sponsors are Trio Medicines Ltd., University of Cambridge, and National Institute for Health Research, United Kingdom.
Recent Clinical Trials for Netazepide
|YF476 in Barrett's Esophagus||Columbia University||Phase 2|
|YF476 in Barrett's Esophagus||University of Cambridge||Phase 2|
|YF476 in Barrett's Esophagus||Trio Medicines Ltd.||Phase 2|